Skip to content

Demetrius Perry

3 papers in the library · 413 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

Psilocybin’s acute and persistent brain effects: a precision imaging drug trial

Scientific Data June 5, 2025 Subha Subramanian, Travis Rick Renau, Demetrius Perry et al. 4 citations

Psilocybin (PSIL) is a psychedelic drug and a promising experimental therapeutic for many psychiatric conditions. Precision functional mapping (PFM) combines densely repeated resting state fMRI sampling and individual-specific network mapping to improve signal-to-noise ratio (SNR) and effect size in brain imaging research. We present a randomized cross-over study in which PFM was used to...

Psilocybin desynchronizes the human brain.

Nature August 1, 2024 Joshua S. Siegel, Subha Subramanian, Demetrius Perry et al. 241 citations

A single dose of psilocybin, a psychedelic that acutely causes distortions of space-time perception and ego dissolution, produces rapid and persistent therapeutic effects in human clinical trials1-4. In animal models, psilocybin induces neuroplasticity in cortex and hippocampus5-8. It remains unclear how human brain network changes relate to subjective and lasting effects of psychedelics. Here...

Psychedelic Drug Legislative Reform and Legalization in the US

JAMA Psychiatry December 7, 2022 Joshua S. Siegel, James E. Daily, Demetrius Perry et al. 168 citations

Importance Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care professionals, and planning for implementation and regulation. Objective To assess trends in psychedelics legislative reform and legalization in the US to provide guidance to health care...